What is the share price of MedPlus Health Services Limited (MEDPLUS) today?
The share price of MEDPLUS as on 18th September 2026 is ₹659.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on MedPlus Health Services Limited (MEDPLUS) share?
The past returns of MedPlus Health Services Limited (MEDPLUS) share are- Past 1 week: 0.47%
- Past 1 month: 0.27%
- Past 3 months: -22.48%
- Past 6 months: -21.97%
- Past 1 year: -21.31%
- Past 3 years: -17.86%
- Past 5 years: -41.16%
What are the peers or stocks similar to MedPlus Health Services Limited (MEDPLUS)?
The peers or stocks similar to MedPlus Health Services Limited (MEDPLUS) include:What is the market cap of MedPlus Health Services Limited (MEDPLUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of MedPlus Health Services Limited (MEDPLUS) is ₹7921.58 Cr as of 18th September 2026.What is the 52 week high and low of MedPlus Health Services Limited (MEDPLUS) share?
The 52-week high of MedPlus Health Services Limited (MEDPLUS) is ₹1022.20 and the 52-week low is ₹645.What is the PE and PB ratio of MedPlus Health Services Limited (MEDPLUS) stock?
The P/E (price-to-earnings) ratio of MedPlus Health Services Limited (MEDPLUS) is 36.06. The P/B (price-to-book) ratio is 4.01.Which sector does MedPlus Health Services Limited (MEDPLUS) belong to?
MedPlus Health Services Limited (MEDPLUS) belongs to the Communication Services sector & Online Services sub-sector.How to buy MedPlus Health Services Limited (MEDPLUS) shares?
You can directly buy MedPlus Health Services Limited (MEDPLUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
MedPlus Health Services Limited
MEDPLUS Share Price
NSE₹659.651.02% (+6.65)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDPLUS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
MEDPLUS Performance & Key Metrics
MEDPLUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 37.64 | 4.01 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 33.72 | 6.41 | 1.08% |
100%
Analysts have suggested that investors can buy this stock
from 7 analysts
Price Upside
Earnings Growth
Rev. Growth
MEDPLUS Company Profile
Medplus Health Services Pvt Ltd is an India-based retail pharmacy company. The Company helps customers to access its products, bills and all health records through online store, medplusmart.com, or on mobile through the MedPlus application.
ETERNAL
PE Ratio
822.07
822.07
1Y Return
3.26%
3.26%
Buy Reco %
90.63
90.63
PE Ratio
214.63
214.63
1Y Return
50.48%
50.48%
Buy Reco %
76.19
76.19
NAUKRI
PE Ratio
55.91
55.91
1Y Return
9.65%
9.65%
Buy Reco %
86.36
86.36
POLICYBZR
PE Ratio
120.23
120.23
1Y Return
2.60%
2.60%
Buy Reco %
72.73
72.73
SWIGGY
PE Ratio
-17.13
-17.13
1Y Return
38.57%
38.57%
Buy Reco %
66.67
66.67
MEDPLUS Sentiment Analysis
MEDPLUS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MEDPLUS Stock Summary · July 2026
Management framed the quarter as one of rapid network expansion and solid underlying pharmacy-led growth, while also acknowledging margin pressure from rising employee costs and a still-developing franchise model. Q1 FY27 store count reached 5,476 after 146 net additions, with pharmacy revenue up 21.8% year over year and consolidated revenue at INR18,796 million, producing operating EBITDA of INR651 million and a 3.5% margin. Management said pharmacy remains the core driver as the store base scales, and noted that older stores are much more productive, with locations older than 12 months generating 94% of pharmacy sales and a 10.4% store-level EBITDA margin. At the same time, franchise stores made up 131 of the quarter’s 146 net additions, well above earlier expectations, and management described the model as strategically important but still being refined. They also discussed pricing and fee changes to support profitability, while employee expense pressure from wage hikes and new warehouse staffing was expected to weigh more fully in coming quarters. Near term, the company kept its FY27 target of 800 net new stores and said core store and warehousing investment will continue, while discretionary capex remains on hold.
MEDPLUS Stock Growth Drivers
MEDPLUS Stock Growth Drivers
8Store Network Expansion and Franchise-Led Scaling
MedPlus continues to expand its store base at a strong pace, with 222 gross openings
Growing Core Pharmacy Business and Same-Store Momentum
The core pharmacy business delivered strong operating momentum, with pharmacy revenue up 21.8% year over
MEDPLUS Stock Challenges
MEDPLUS Stock Challenges
8Capex Freeze and Strategic Pause
The company has put all approved and planned capital expenditure on hold, including projects such
Employee Cost Inflation and Margin Pressure
Operating costs are rising materially because of added warehouse headcount, wage increases in Karnataka and
MEDPLUS Forecast
MEDPLUS Forecasts
Price
Revenue
Earnings
MEDPLUS Share Price Forecast
MEDPLUS Share Price Forecast
2026
Current
₹659.65
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹659.65
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDPLUS Company Revenue Forecast
MEDPLUS Company Revenue Forecast
2026
Current
₹6.96
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹6.96
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MEDPLUS Stock EPS (Earnings Per Share) Forecast
MEDPLUS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹18.32
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹18.32
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDPLUS
MEDPLUS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
MEDPLUS Income Statement
MEDPLUS Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,500.96 | 1,497.54 | 1,587.77 | 1,573.96 | 1,525.40 | 1,557.65 | 1,696.80 | 1,824.36 | 1,884.98 | 1,899.43 | ||||||||||
Operating & Other expenses | 1,384.63 | 1,395.06 | 1,451.73 | 1,428.92 | 1,373.24 | 1,411.90 | 1,530.48 | 1,647.50 | 1,695.21 | 1,746.36 | ||||||||||
EBITDA | 116.33 | 102.48 | 136.04 | 145.04 | 152.16 | 145.75 | 166.32 | 176.86 | 189.77 | 153.07 | ||||||||||
| Depreciation/Amortization | 59.22 | 60.03 | 63.14 | 62.47 | 64.21 | 65.62 | 68.56 | 72.74 | 75.95 | 77.92 | ||||||||||
| PBIT | 57.11 | 42.45 | 72.90 | 82.57 | 87.95 | 80.13 | 97.76 | 104.12 | 113.82 | 75.15 | ||||||||||
| Interest & Other Items | 25.13 | 24.66 | 25.12 | 25.97 | 26.84 | 27.37 | 28.82 | 30.83 | 33.48 | 33.27 | ||||||||||
| PBT | 31.98 | 17.79 | 47.78 | 56.60 | 61.11 | 52.76 | 68.94 | 73.29 | 80.34 | 41.88 | ||||||||||
| Taxes & Other Items | -1.41 | 3.42 | 9.05 | 10.71 | 9.78 | 10.40 | 13.43 | 15.48 | 16.36 | 8.70 | ||||||||||
| Net Income | 33.39 | 14.37 | 38.73 | 45.89 | 51.33 | 42.36 | 55.51 | 57.81 | 63.98 | 33.18 | ||||||||||
| EPS | 2.81 | 1.20 | 3.24 | 3.84 | 4.32 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 |
MEDPLUS Company Updates
FY 2027FY 2027
Investor Presentation
Jul 21PDF
Jul 21PDF
MEDPLUS Stock Peers
MEDPLUS Past Performance & Peer Comparison
MEDPLUS Past Performance & Peer Comparison
Comparing 3 stocks from
Communication ServicesOnline Services
Compare valuation on Screener
Communication ServicesOnline Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| MedPlus Health Services Limited | 36.06 | 4.01 | — |
| Eternal Limited | 822.07 | 9.71 | — |
| One 97 Communications Ltd | 214.63 | 7.41 | — |
| Info Edge (India) Ltd | 55.91 | 2.01 | 0.67% |
MEDPLUS Stock Price Comparison
Compare MEDPLUS with any stock or ETFCompare MEDPLUS with any stock or ETF
MEDPLUS
MEDPLUS Holdings
MEDPLUS Shareholdings
MEDPLUS Promoter Holdings Trend
MEDPLUS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
MEDPLUS Institutional Holdings Trend
MEDPLUS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.15%
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding History
MEDPLUS Shareholding History
Foreign Institutions
Mutual Funds Invested in MEDPLUS
Mutual Funds Invested in MEDPLUS
No mutual funds holding trends are available
Top 5 Mutual Funds holding MedPlus Health Services Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.6642% | Percentage of the fund’s portfolio invested in the stock 4.15% | Change in the portfolio weight of the stock over the last 3 months 0.49% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/41 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.5137% | Percentage of the fund’s portfolio invested in the stock 0.86% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/96 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0368% | Percentage of the fund’s portfolio invested in the stock 1.22% | Change in the portfolio weight of the stock over the last 3 months -0.33% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/84 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MEDPLUS stock
smallcases containing MEDPLUS stock
Looks like this stock is not in any smallcase yet.
MEDPLUS Events
MEDPLUS Events
MEDPLUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDPLUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDPLUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDPLUS has not given any dividends in last 5 years
MEDPLUS Dividends
MEDPLUS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMEDPLUS Stock News & Opinions
MEDPLUS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Medplus Health Services acquires remaining stake in Optival Health Solutions for Rs 1.10 croreMedplus Health Services Limited announced that its board approved the acquisition of the remaining 0.01% stake in Optival Health Solutions Private Limited, a material subsidiary, from its remaining shareholders for a cash consideration of Rs 1.10 crore. Following the acquisition, Medplus Health Services Limited will own 100% of Optival Health Solutions Private Limited, making it a wholly owned subsidiary. Optival Health Solutions Private Limited, incorporated on July 11, 2005, reported a turnover of Rs 6816.44 crore for the fiscal year 2025-26 and operates in the pharmacy retail business in India.
1 week agoCapital Market - Live
Corporate
Corporate
MedPlus Health Sevices board approves suspension of capex plansThe board of MedPlus Health Services at its meeting held on 23 July 2026 after reviewing the present business structure and market outlook has approved to keep in abeyance the implementation of both the capex plan viz. setting up of food park by Optival Health Solutions (a material subsidiary) and setting up a concierge health & wellness services facility at Hyderabad, Telangana.
1 month agoCapital Market - Live
Corporate
Corporate
Medplus Health Services AGM scheduledMedplus Health Services announced that the 20th Annual General Meeting(AGM) of the company will be held on 17 August 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Medplus Health Services consolidated net profit declines 21.67% in the June 2026 quarterNet profit of Medplus Health Services declined 21.67% to Rs 33.18 crore in the quarter ended June 2026 as against Rs 42.36 crore during the previous quarter ended June 2025. Sales rose 21.84% to Rs 1879.60 crore in the quarter ended June 2026 as against Rs 1542.63 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1879.601542.63 22 OPM %7.098.47 - PBDT119.80118.38 1 PBT41.8852.77 -21 NP33.1842.36 -22 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Medplus Health Services to hold board meetingMedplus Health Services will hold a meeting of the Board of Directors of the Company on 21 July 2026.
2 months agoCapital Market - Live
Spotlight
Spotlight
Medplus rises after Q4 PAT jumps 25% YoY to Rs 64 crProfit before tax (PBT) climbed 31.45% to Rs 80.34 crore in Q4 FY26. EBITDA stood at Rs 189.77 crore in Q4 FY26, registering the growth of 24.71% compared with Rs 152.17 crore posted in the corresponding quarter last year. EBITDA margin improved to 10.2% in Q4 FY26 as against 10.1% in Q4 FY25. On the segmental front, revenue from the retail segment rose 23.48% YoY to Rs 1,828.98 crore, while revenue from diagnostic services grew 23.86% YoY to Rs 34.78 crore in Q4 FY26. On a full-year basis, consolidated net profit jumped 46.12% to Rs 219.65 crore on a 12.33% rise in revenue to Rs 6,892.47 crore in FY26 over FY25. Meanwhile, the company said it has approved the re-appointment of Mr. Gangadi Madhukar Reddy as managing director for a period of five years, commencing August 03, 2026, subject to approval of the company's members. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing, and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Earnings
Medplus Health Services consolidated net profit rises 24.62% in the March 2026 quarterNet profit of Medplus Health Services rose 24.62% to Rs 63.98 crore in the quarter ended March 2026 as against Rs 51.34 crore during the previous quarter ended March 2025. Sales rose 23.50% to Rs 1864.39 crore in the quarter ended March 2026 as against Rs 1509.61 crore during the previous quarter ended March 2025. For the full year,net profit rose 46.12% to Rs 219.65 crore in the year ended March 2026 as against Rs 150.32 crore during the previous year ended March 2025. Sales rose 12.33% to Rs 6892.47 crore in the year ended March 2026 as against Rs 6136.05 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1864.391509.61 24 6892.476136.05 12 OPM %9.079.03 -8.817.94 - PBDT156.29125.33 25 558.20433.13 29 PBT80.3461.12 31 275.33183.29 50 NP63.9851.34 25 219.65150.32 46 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Medplus Health Services to announce Quarterly ResultMedplus Health Services will hold a meeting of the Board of Directors of the Company on 29 May 2026.
5 months agoCapital Market - Live
Earnings
Earnings
Medplus Health Services consolidated net profit rises 25.98% in the December 2025 quarterNet profit of Medplus Health Services rose 25.98% to Rs 57.81 crore in the quarter ended December 2025 as against Rs 45.89 crore during the previous quarter ended December 2024. Sales rose 15.67% to Rs 1806.12 crore in the quarter ended December 2025 as against Rs 1561.45 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1806.121561.45 16 OPM %8.788.49 - PBDT146.03119.07 23 PBT73.2956.60 29 NP57.8145.89 26 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Medplus Health Services schedules board meetingMedplus Health Services will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.64%, vs industry avg of 45.5%
Over the last 5 years, market share decreased from 16.97% to 5.56%